Scopus Biopharma Inc
Scopus BioPharma Inc., a clinical-stage biopharmaceutical company, focuses on developing transformational therapeutics targeting serious diseases with unmet medical needs. It offers Duet Platform, which consists of signal transducer and activator of transcription 3 (STAT3), a master immune checkpoint inhibitor and toll-like receptor 9 (TLR9), as well as includes CpG-STAT3ASO (DUET-02), CpG-STAT3s… Read more
Market Cap & Net Worth: Scopus Biopharma Inc (SCPS)
Scopus Biopharma Inc (OTCMKTS:SCPS) has a market capitalization of $12.63K ($12.63K) as of March 19, 2026. Listed on the OTCMKTS stock exchange, this USA-based company holds position #44924 globally and #14178 in its home market, demonstrating a 0.00% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Scopus Biopharma Inc's stock price $0.00 by its total outstanding shares 42084264 (42.08 Million).
Scopus Biopharma Inc Market Cap History: 2020 to 2025
Scopus Biopharma Inc's market capitalization history from 2020 to 2025. Data shows change from $624.53 Million to $12.63K (-89.97% CAGR).
Scopus Biopharma Inc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Scopus Biopharma Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of SCPS by Market Capitalization
Companies near Scopus Biopharma Inc in the global market cap rankings as of March 19, 2026.
Key companies related to Scopus Biopharma Inc by market ranking:
- Vertex Pharmaceuticals Inc (NASDAQ:VRTX): Ranked #165 globally with a market cap of $114.33 Billion USD.
- Regeneron Pharmaceuticals Inc (NASDAQ:REGN): Ranked #285 globally with a market cap of $73.32 Billion USD.
- CSL Limited (PINK:CMXHF): Ranked #340 globally with a market cap of $63.46 Billion USD.
- argenx SE (OTCGREY:ARGNF): Ranked #497 globally with a market cap of $42.99 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #165 | Vertex Pharmaceuticals Inc | NASDAQ:VRTX | $114.33 Billion | $451.59 |
| #285 | Regeneron Pharmaceuticals Inc | NASDAQ:REGN | $73.32 Billion | $744.12 |
| #340 | CSL Limited | PINK:CMXHF | $63.46 Billion | $149.87 |
| #497 | argenx SE | OTCGREY:ARGNF | $42.99 Billion | $697.42 |
Scopus Biopharma Inc Historical Marketcap From 2020 to 2025
Between 2020 and today, Scopus Biopharma Inc's market cap moved from $624.53 Million to $ 12.63K, with a yearly change of -89.97%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2025 | $12.63K | 0.00% |
| 2024 | $12.63K | -99.30% |
| 2023 | $1.81 Million | -56.12% |
| 2022 | $4.12 Million | -94.01% |
| 2021 | $68.81 Million | -88.98% |
| 2020 | $624.53 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 19th, 2026 the market cap of Scopus Biopharma Inc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $12.63K USD |
| MoneyControl | $12.63K USD |
| MarketWatch | $12.63K USD |
| marketcap.company | $12.63K USD |
| Reuters | $12.63K USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.